New York State Common Retirement Fund’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-316
Closed 3580
2021
Q2
$0 Sell
316
-35,684
-99% -$66.1K ﹤0.01% 3585
2021
Q1
$80K Hold
36,000
﹤0.01% 3125
2020
Q4
$89K Hold
36,000
﹤0.01% 3072
2020
Q3
$89K Hold
36,000
﹤0.01% 2981
2020
Q2
$128K Buy
+36,000
New +$114K ﹤0.01% 2841
2019
Q2
Sell
-15,900
Closed -$31K 3320
2019
Q1
$31K Hold
15,900
﹤0.01% 3112
2018
Q4
$21K Hold
15,900
﹤0.01% 3157
2018
Q3
$39K Hold
15,900
﹤0.01% 3117
2018
Q2
$53K Buy
15,900
+8,000
+101% +$30.7K ﹤0.01% 3142
2018
Q1
$33K Hold
7,900
﹤0.01% 3050
2017
Q4
$26K Buy
7,900
+2,800
+55% +$10.2K ﹤0.01% 3068
2017
Q3
$19K Hold
5,100
﹤0.01% 3081
2017
Q2
$22K Buy
+5,100
New +$20.9K ﹤0.01% 3165

Other funds holding NYMX

New York State Common Retirement Fund's NYMX Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2021, closing a stake of 316 shares.

New York State Common Retirement Fund first reported a position in NYMX in Q2 2017 and held it in 13 quarters. The position peaked at $128K in Q2 2020. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Nymox Pharmaceutical Corp position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 316 Nymox Pharmaceutical Corp shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 13 quarters.
  • New York State Common Retirement Fund's Nymox Pharmaceutical Corp position peaked at $128K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.